Every minute, a woman in the U.S. requires a blood transfusion due to heavy menstrual bleeding, or HMB. One in three women reports having the condition—which can lead to iron deficiency and anemia—and missing an average of 3.6 weeks of work a year, costing the U.S. economy roughly $94 billion annually, according to the nonprofit Wellcome Leap. Patients routinely suffer for up to five years before they get help, despite HMB being more common than asthma or diabetes in reproductive-aged women.
This article was originally published on MedicalXpress.com
